Aziridines

Last updated
Mitomycin C, an aziridine, is used as a chemotherapeutic agent by virtue of its antitumour activity. Mitomycin.svg
Mitomycin C, an aziridine, is used as a chemotherapeutic agent by virtue of its antitumour activity.

In organic chemistry, aziridines are organic compounds containing the aziridine functional group (chemical structure (R−)4C2N−R), a three-membered heterocycle with one amine (>NR) and two methylene bridges (>CR2). [2] [3] [4] The parent compound is aziridine (or ethylene imine), with molecular formula C2H4NH. Several drugs feature aziridine rings, including zoldonrasib, thiotepa, mitomycin C, porfiromycin, and azinomycin B (carzinophilin). [5]

Contents

Structure

The bond angles in aziridine are approximately 60°, considerably less than the normal hydrocarbon bond angle of 109.5°, which results in angle strain as in the comparable cyclopropane and ethylene oxide molecules. A banana bond model explains bonding in such compounds. Aziridine is less basic than acyclic aliphatic amines, with a pKa of 7.9 for the conjugate acid, due to increased s character of the nitrogen free electron pair. Angle strain in aziridine also increases the barrier to nitrogen inversion. This barrier height permits the isolation of separate invertomers, for example the cis and trans invertomers of N-chloro-2-methylaziridine.

Synthesis

Several routes have been developed for the syntheses of aziridines (aziridination).

Vicinal cyclization

Haloamines, aminoalcohols and azidoalcohols

In vicinal haloamines, the amine functional group spontaneously displaces the adjacent halide to generate an aziridine. The reaction is an intramolecular nucleophilic substitution, similar to the base-induced cyclization of halohydrins to epoxides. With appropriate activating agents, vicinal cyclization is similarly possible with aminoalcohols, themselves efficiently produced from opening epoxides with amines. [6]

The parent aziridine is produced industrially from aminoethanol via two related routes. The Nippon Shokubai process requires an oxide catalyst and high temperatures to effect the dehydration. In the Wenker synthesis, the aminoethanol is converted to the sulfate ester, which undergoes base-induced sulfate elimination. [7]

In the laboratory, aminoalcohols can be induced to cyclize with the Mitsunobu reaction, [6] but Mitsunobu conditions more fruitfully apply to 2-azido alcohols. Trialkyl phosphines such as trimethylphosphine or tributylphosphine reduce azidoalcohols to an αalcohol phosphine imide, which then cyclizes to an aziridine. [8] [9]

In the Blum-Ittah aziridine synthesis, the initial azidoalcohol forms when sodium azide opens an epoxide: [10]

Aziridine synthesis Hili 2006 AziridineSynthesisFromEpoxide.png
Aziridine synthesis Hili 2006

Darzens-like reactions

The De Kimpe aziridine synthesis allows for the generation of aziridines by reacting an α-chloroimine with a nucleophile, such as hydride, cyanide, or a Grignard reagent. [11] [12]

The Hoch-Campbell ethylenimine synthesis involves the reaction of certain oximes with Grignard reagents, which affords aziridines: [13]

Hoch-Campbell Ethylenimine Synthesis Hoch-Campbell Ethylenimine Synthesis.svg
Hoch-Campbell Ethylenimine Synthesis

Nitrene addition and triazoline contraction

Nitrene addition to alkenes is a well-established method for the synthesis of aziridines, and occurs for a wide variety of nitrenoid precursors.

Nitrenes can be prepared in situ when iodosobenzene diacetate oxidizes various amides, or from deprotonation of an aminoester: [14]

Nitrene addition Nitreneaddition.png
Nitrene addition

Rhodium(II) carboxylates catalyze nitrene formation from O-(2,4-dinitrophenyl)hydroxylamine  [ de ] (DPH), which then aziridates a mono-, di-, tri- or tetra-substituted alkene (olefin): [15]

alkene + DPH aziridine

Alternatively, photolysis or thermolysis of organic azides are good ways to generate nitrenes. The same conditions also contract triazolines, expelling nitrogen and producing an aziridine.

Reactions

Nucleophilic ring opening

Aziridines are reactive substrates in ring-opening reactions with many nucleophiles due to their ring strain. Alcoholysis and aminolysis are basically the reverse reactions of the cyclizations. Carbon nucleophiles such as organolithium reagents and organocuprates are also effective. [16] [17]

One application of a ring-opening reaction in asymmetric synthesis is that of trimethylsilylazide TMSN
3
with an asymmetric ligand [18] in scheme 2 [19] in an organic synthesis of oseltamivir:

Synthesis of Tamiflu via a Catalytic Asymmetric Ring-Opening of meso-Aziridines with TMSN3 TamifluSynthesisII.png
Synthesis of Tamiflu via a Catalytic Asymmetric Ring-Opening of meso-Aziridines with TMSN3

1,3-dipole formation

Certain N-substituted azirines with electron withdrawing groups on both carbons form azomethine ylides in an electrocyclic thermal or photochemical ring-opening reaction. [20] [21] These ylides can be trapped with a suitable dipolarophile in a 1,3-dipolar cycloaddition. [22]

Aziridine ring opening.svg

When the N-substituent is an electron-withdrawing group such as a tosyl group, the carbon-nitrogen bond breaks, forming another zwitterion TsN
–CH
2
–CH+
2
–R
[23]

2-phenyl-N-tosyl-aziridine cycloadditions.svg

This reaction type requires a Lewis acid catalyst such as boron trifluoride. In this way 2-phenyl-N-tosylaziridine reacts with alkynes, nitriles, ketones and alkenes. Certain 1,4-dipoles form from azetidines.

Other

Lewis acids, such as B(C
6
F
5
)
3
, can induce decomposition of the ring to a carbocation and linear azanide, which then attack unsaturated moieties in tandem. [24] Oxidation to the N-oxide instead induces nitroso compound extrusion, leaving an olefin. [25]

Safety

As electrophiles, aziridines are subject to attack and ring-opening by endogenous nucleophiles such as nitrogenous bases in DNA base pairs, resulting in potential mutagenicity. [26] [27] [28]

The International Agency for Research on Cancer (IARC) classifies aziridine compounds as possibly carcinogenic to humans (IARC Group 2B). [29] In making the overall evaluation, the IARC Working Group took into consideration that aziridine is a direct-acting alkylating agent, which is mutagenic in a wide range of test systems and forms DNA adducts that are promutagenic. The features that are responsible for their mutagenicity are relevant to their beneficial medicinal properties. [5]

See also

References

  1. Tomasz, Maria (September 1995). "Mitomycin C: small, fast and deadly (but very selective)". Chemistry and Biology. 2 (9): 575–579. doi: 10.1016/1074-5521(95)90120-5 . PMID   9383461.
  2. Gilchrist, T.L. (1987). Heterocyclic chemistry. Longman Scientific & Technical. ISBN   978-0-582-01421-3.
  3. Epoxides and Aziridines – A Mini Review Albert Padwa and S. Shaun Murphree Arkivoc (JC-1522R) pp. 6–33 Online article
  4. Sweeney, J. B. (2002). "Aziridines: Epoxides' ugly cousins?". Chem. Soc. Rev. 31 (5): 247–258. doi:10.1039/B006015L. PMID   12357722.
  5. 1 2 Ismail, Fyaz M.D.; Levitsky, Dmitri O.; Dembitsky, Valery M. (2009). "Aziridine alkaloids as potential therapeutic agents". European Journal of Medicinal Chemistry. 44 (9): 3373–3387. doi:10.1016/j.ejmech.2009.05.013. PMID   19540628.
  6. 1 2 B. Pulipaka; Stephen C. Bergmeier (2008). "Synthesis of Hexahydro-1 H -benzo[ c ]chromen-1-amines via the Intramolecular Ring-Opening Reof Aziridines by π-Nucleophiles". Synthesis. 2008 (9): 1420–30. doi:10.1055/s-2008-1072561.
  7. Steuerle, Ulrich; Feuerhake, Robert (2006). "Aziridines". Ullmann's Encyclopedia of Industrial Chemistry . Weinheim: Wiley-VCH. doi:10.1002/14356007.a03_239.pub2. ISBN   3527306730.
  8. Ittah, Ytzhak; Sasson, Yoel; Shahak, Israel; Tsaroom, Shalom; Blum, Jochanan (1 October 1978). "A new aziridine synthesis from 2-azido alcohols and tertiary phosphines. Preparation of phenanthrene 9,10-imine". The Journal of Organic Chemistry. 43 (22): 4271–4273. doi:10.1021/jo00416a003.
  9. Breuning, Alexander; Vicik, Radim; Schirmeister, Tanja (31 October 2003). "An improved synthesis of aziridine-2,3-dicarboxylates via azido alcohols—epimerization studies". Tetrahedron: Asymmetry. 14 (21): 3301–3312. doi:10.1016/j.tetasy.2003.09.015.
  10. Ryan Hili; Andrei K. Yudin (2006). "Readily Available Unprotected Amino Aldehydes". J. Am. Chem. Soc. 128 (46): 14772–3. Bibcode:2006JAChS.12814772H. doi:10.1021/ja065898s. PMID   17105264.
  11. De Kimpe, Norbert; Moens, Luc (6 February 1990). "Synthesis of 1,2,3-trisubstituted and 1,2,2,3-tetrasubstituted aziridines from α-chloroketimines". Tetrahedron. 46 (8): 2965–2974. doi:10.1016/S0040-4020(01)88388-5.
  12. "Asymmetric Synthesis of Aziridines by Reduction of N-tert-Butanesulfinyl α-Chloro Imines". The Journal of Organic Chemistry. 72 (9): 3211–3217. 31 March 2007. doi:10.1021/jo0624795. PMID   17397222.
  13. "Hoch-Campbell Reaction". Comprehensive Organic Name Reactions and Reagents. 2010. pp. 1434–1437. doi:10.1002/9780470638859.conrr320. ISBN   9780470638859.
  14. M. Antonietta Loreto; Lucio Pellacani; Paolo A. Tardella; Elena Toniato (1984). "Addition reactions of ethoxycarbonylnitrene and ethoxycarbonylnitrenium ion to allylic ethers". Tetrahedron Letters. 25 (38): 4271–4. doi:10.1016/S0040-4039(01)81414-3.
  15. Jat, Jawahar L.; Paudyal, Mahesh P.; Gao, Hongyin; Xu, Qing-Long; Yousufuddin, Muhammed; Devarajan, Deepa; Ess, Daniel H.; Kürti, László; Falck, John R. (2014-01-03). "Direct Stereospecific Synthesis of Unprotected N-H and N-Me Aziridines from Olefins". Science. 343 (6166): 61–65. Bibcode:2014Sci...343...61J. doi:10.1126/science.1245727. ISSN   0036-8075. PMC   4175444 . PMID   24385626.
  16. Hu, X.Eric (2004). "Nucleophilic ring opening of aziridines". Tetrahedron. 60 (12): 2701–2743. doi:10.1016/j.tet.2004.01.042.
  17. McCoull, William; Davis, Franklin A. (2000). "Recent Synthetic Applications of Chiral Aziridines". Synthesis. 2000 (10): 1347–1365. doi:10.1055/s-2000-7097. S2CID   97141326.
  18. Yuhei Fukuta; Tsuyoshi Mita; Nobuhisa Fukuda; Motomu Kanai; Masakatsu Shibasaki (2006). "De Novo Synthesis of Tamiflu via a Catalytic Asymmetric Ring-Opening of meso-Aziridines with TMSN3". J. Am. Chem. Soc. 128 (19): 6312–3. Bibcode:2006JAChS.128.6312F. doi:10.1021/ja061696k. PMID   16683784.
  19. The catalyst is based on yttrium with three isopropyloxy substituents and the ligand a phosphine oxide (Ph = phenyl), with 91% enantiomeric excess (ee)
  20. Harold W. Heine; Richard Peavy (1965). "Aziridines XI. Reaction of 1,2,3-triphenylaziridine with diethylacetylene dicarboxylate and maleic anhydride". Tetrahedron Letters . 6 (35): 3123–6. doi:10.1016/S0040-4039(01)89232-7.
  21. Albert Padwa; Lewis Hamilton (1965). "Reactions of aziridines with dimethylacetylene dicarboxylate". Tetrahedron Letters . 6 (48): 4363–7. doi:10.1016/S0040-4039(00)71101-4.
  22. Philippe Dauban; Guillaume Malik (2009). "A Masked 1,3-Dipole Revealed from Aziridines". Angew. Chem. Int. Ed. 48 (48): 9026–9. doi:10.1002/anie.200904941. PMID   19882612.
  23. Ioana Ungureanua; Cristian Bologab; Saïd Chayera; André Mann (16 July 1999). "Phenylaziridine as a 1,3-dipole. Application to the synthesis of functionalized pyrrolidines". Tetrahedron Letters . 40 (29): 5315–8. doi:10.1016/S0040-4039(99)01002-3.
  24. Aravinda B. Pulipaka; Stephen C. Bergmeier (2008). "A Synthesis of 6-Azabicyclo[3.2.1]octanes. The Role of N-Substitution". J. Org. Chem. 73 (4): 1462–7. doi:10.1021/jo702444c. PMID   18211092.
  25. Hata, Yoshiteru; Watanabe, Masamichi (January 1994). "Metabolism of Aziridines and the Mechanism of their Cytotoxicity" . Drug Metabolism Reviews. 26 (3): 575–604. doi:10.3109/03602539408998318. ISSN   0360-2532. PMID   7924904.
  26. Kanerva L, Keskinen H, Autio P, Estlander T, Tuppurainen M, Jolanki R (May 1995). "Occupational respiratory and skin sensitization caused by polyfunctional aziridine hardener". Clin Exp Allergy. 25 (5): 432–9. doi:10.1111/j.1365-2222.1995.tb01074.x. PMID   7553246. S2CID   28101810.
  27. Sartorelli P, Pistolesi P, Cioni F, Napoli R, Sisinni AG, Bellussi L, Passali GC, Cherubini Di Simplicio E, Flori L (2003). "Skin and respiratory allergic disease caused by polyfunctional aziridine". Med Lav. 94 (3): 285–95. PMID   12918320.
  28. Mapp CE (2001). "Agents, old and new, causing occupational asthma". Occup. Environ. Med. 58 (5): 354–60. doi:10.1136/oem.58.5.354. PMC   1740131 . PMID   11303086.
  29. Some Aziridines, N-, S- and O-Mustards and Selenium (PDF). IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol. 9. 1975. ISBN   978-92-832-1209-6. Archived from the original (PDF) on 2009-11-14. Retrieved 2019-11-24.